Thomas Takashima, PHARMD
Pharmacotherapy · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Thomas Takashima’s office at (408) 851-9006 to ask if they take your plan before you enroll.
California Medical Board record
Licence A48281 · Current
Licence status: Current · since 1990 · expires 2028-01-31 · University of Cairo Faculty of Medicine. Board flags: Inactive.
Licensee meets requirements for the practice of medicine in California.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$100,007
Pharmacies billed $100,007 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 369) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
58 generic and 251 brand-name prescriptions · $100,007 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 38 | $28,131 | $740 |
| Humalog | 59 | $18,089 | $307 |
| Humalog Kwikpen U-100 | 43 | $12,194 | $284 |
| Insulin Glargine-Yfgn | 36 | $5,269 | $146 |
| Humulin N | 18 | $1,944 | $108 |
See all 11 drugs
| Ozempic | 38 | $28,131 | $740 |
| Humalog | 59 | $18,089 | $307 |
| Humalog Kwikpen U-100 | 43 | $12,194 | $284 |
| Insulin Glargine-Yfgn | 36 | $5,269 | $146 |
| Humulin N | 18 | $1,944 | $108 |
| Humulin N Kwikpen | 14 | $1,727 | $123 |
| Ultra-Fine Nano Pen Needle | 13 | $453 | $35 |
| Veo Insulin | 11 | $255 | $23 |
| Atorvastatin | 18 | $234 | $13 |
| Metformin Hcl Er | 22 | $207 | $9 |
| Glipizide | 15 | $155 | $10 |
Year by year
| 2024 | 369 | 74 | 0% (0) | 68% | $100,007 |
| 2023 | 456 | 94 | 0% (0) | 65% | $111,837 |
| 2022 | 424 | 92 | 0% (0) | 59% | $86,765 |
| 2021 | 326 | 72 | 0% (0) | 60% | $58,395 |
| 2020 | 299 | 72 | 0% (0) | 65% | $66,275 |
| 2019 | 280 | 76 | 0% (0) | 62% | $48,122 |
| 2018 | 514 | 165 | 0% (0) | 50% | $69,895 |
| 2017 | 544 | 168 | 0% (0) | 51% | $65,183 |
| 2016 | 389 | 96 | 0% (0) | 58% | $40,723 |
| 2015 | 210 | 78 | 0% (0) | 51% | $18,010 |
| 2014 | 200 | 74 | 0% (0) | 49% | $16,551 |
| 2013 | 189 | 87 | 0% (0) | 57% | $21,377 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Humalog | 77 | $24,403 | $317 |
| Ozempic | 25 | $20,166 | $807 |
| Humalog Kwikpen U-100 | 37 | $12,153 | $328 |
| Humulin N | 37 | $4,102 | $111 |
| Lantus | 17 | $3,804 | $224 |
| Insulin Glargine-Yfgn | 17 | $2,661 | $157 |
| Humulin N Kwikpen | 22 | $2,428 | $110 |
| Humulin R | 20 | $2,144 | $107 |
| Ultra-Fine Nano Pen Needle | 20 | $643 | $32 |
| Ultra-Fine Short Pen Needle | 15 | $525 | $35 |
| Veo Insulin | 16 | $454 | $28 |
| Veo Insulin | 14 | $444 | $32 |
| Glipizide | 27 | $286 | $11 |
| Atorvastatin | 18 | $243 | $13 |
| Metformin Hcl Er | 24 | $235 | $10 |
2022: 14 drugs
| Victoza 2-Pak | 24 | $21,069 | $878 |
| Humalog | 55 | $15,147 | $275 |
| Lantus | 37 | $9,547 | $258 |
| Humalog Kwikpen U-100 | 32 | $7,911 | $247 |
| Humulin N | 32 | $3,687 | $115 |
| Humulin N Kwikpen | 18 | $2,000 | $111 |
| Humulin R | 16 | $1,530 | $96 |
| Ultra-Fine Short Pen Needle | 27 | $992 | $37 |
| Veo Insulin | 20 | $717 | $36 |
| Ultra-Fine Nano Pen Needle | 21 | $668 | $32 |
| Veo Insulin | 26 | $632 | $24 |
| Atorvastatin | 19 | $277 | $15 |
| Metformin Hcl Er | 28 | $250 | $9 |
| Glipizide | 17 | $181 | $11 |
2021: 11 drugs
| Lantus | 31 | $12,455 | $402 |
| Humalog | 36 | $9,090 | $253 |
| Humalog Kwikpen U-100 | 39 | $8,999 | $231 |
| Humulin N | 31 | $4,526 | $146 |
| Humulin N Kwikpen | 21 | $2,236 | $106 |
| Ultra-Fine Short Pen Needle | 28 | $966 | $35 |
| Ultra-Fine Mini Pen Needle | 13 | $815 | $63 |
| Ultra-Fine Nano Pen Needle | 11 | $467 | $42 |
| Veo Insulin | 16 | $398 | $25 |
| Metformin Hcl Er | 19 | $173 | $9 |
| Glipizide | 15 | $145 | $10 |
2020: 10 drugs
| Humalog | 49 | $17,145 | $350 |
| Humalog Kwikpen U-100 | 43 | $9,916 | $231 |
| Lantus | 20 | $9,893 | $495 |
| Humulin N | 26 | $4,050 | $156 |
| Humulin 70/30 Kwikpen | 13 | $1,885 | $145 |
| Humulin R | 11 | $1,861 | $169 |
| Ultra-Fine Short Pen Needle | 23 | $775 | $34 |
| Ultra-Fine Nano Pen Needle | 17 | $459 | $27 |
| Veo Insulin | 21 | $450 | $21 |
| Glipizide | 17 | $175 | $10 |
2019: 9 drugs
| Humalog | 43 | $13,093 | $304 |
| Lantus | 17 | $6,986 | $411 |
| Humulin N | 39 | $6,652 | $171 |
| Humalog Kwikpen U-100 | 27 | $6,535 | $242 |
| Humulin R | 13 | $1,921 | $148 |
| Ultra-Fine Nano Pen Needle | 21 | $807 | $38 |
| Veo Insulin | 32 | $689 | $22 |
| Veo Insulin | 14 | $365 | $26 |
| Glipizide | 11 | $80 | $7 |
2018: 12 drugs
| Humulin N | 87 | $17,342 | $199 |
| Humalog | 38 | $11,167 | $294 |
| Humalog Kwikpen U-100 | 36 | $9,531 | $265 |
| Humulin R | 21 | $3,053 | $145 |
| Veo Insulin | 55 | $1,019 | $19 |
| Atorvastatin | 39 | $1,004 | $26 |
| Ultra-Fine Nano Pen Needle | 25 | $981 | $39 |
| Glipizide | 48 | $727 | $15 |
| Metformin | 30 | $406 | $14 |
| Metformin Hcl Er | 24 | $336 | $14 |
| Veo Insulin | 11 | $333 | $30 |
| Veo Insulin | 15 | $254 | $17 |
2017: 15 drugs
| Lantus | 36 | $19,695 | $547 |
| Humulin N | 83 | $11,740 | $141 |
| Humalog | 34 | $7,619 | $224 |
| Humalog Kwikpen U-100 | 28 | $4,971 | $178 |
| Humulin R | 42 | $4,310 | $103 |
| Humulin 70-30 | 20 | $2,374 | $119 |
| Insulin | 80 | $1,837 | $23 |
| Ultra-Fine Nano Pen Needle | 21 | $971 | $46 |
| Insulin | 23 | $635 | $28 |
| Glipizide | 41 | $595 | $15 |
| Atorvastatin | 22 | $560 | $25 |
| Metformin | 23 | $285 | $12 |
| Insulin | 13 | $276 | $21 |
| Ultra-Fine Short Pen Needle | 11 | $251 | $23 |
| Metformin Hcl Er | 17 | $232 | $14 |
2016: 12 drugs
| Lantus | 17 | $9,176 | $540 |
| Humulin N | 55 | $7,215 | $131 |
| Humalog | 22 | $4,392 | $200 |
| Humulin R | 53 | $4,072 | $77 |
| Humalog Kwikpen U-100 | 22 | $2,792 | $127 |
| Humulin 70-30 | 18 | $1,825 | $101 |
| Bd Ultra-Fine Pen Needle | 39 | $1,179 | $30 |
| Insulin | 48 | $1,131 | $24 |
| Humulin N Kwikpen | 13 | $958 | $74 |
| Insulin | 22 | $499 | $23 |
| Metformin Hcl Er | 17 | $232 | $14 |
| Glipizide | 19 | $228 | $12 |
2015: 6 drugs
| Humulin N | 41 | $3,807 | $93 |
| Humalog | 13 | $2,218 | $171 |
| Bd Ultra-Fine Pen Needle | 22 | $1,713 | $78 |
| Humulin R | 27 | $1,684 | $62 |
| Insulin | 21 | $634 | $30 |
| Insulin | 19 | $535 | $28 |
2014: 7 drugs
| Humalog | 25 | $3,607 | $144 |
| Humulin N | 34 | $2,725 | $80 |
| Bd Ultra-Fine Pen Needle | 30 | $1,921 | $64 |
| Humulin R | 18 | $929 | $52 |
| Insulin | 15 | $496 | $33 |
| Insulin | 12 | $397 | $33 |
| Insulin | 18 | $337 | $19 |
2013: 8 drugs
| Lantus | 19 | $8,332 | $439 |
| Humalog | 17 | $2,168 | $128 |
| Humulin N | 23 | $1,616 | $70 |
| Bd Ultra-Fine Pen Needle | 26 | $1,114 | $43 |
| Humulin R | 20 | $1,113 | $56 |
| Humulin 70-30 | 14 | $913 | $65 |
| Insulin | 16 | $556 | $35 |
| Glipizide | 12 | $182 | $15 |
Professional record
- NPI
- 1447337720
- Licence
- CA 48281California A48281: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1835P1200X (1835P1200X)
- Mailing address
- 710 Lawrence Expy Dept 362, Santa Clara, CA, 95051
- NPI first listed
- 2006-11-01
- NPI last updated
- 2021-12-28
- NPI record certified
- 2021-12-28
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.